Amgen Announces Webcast of Third Quarter Financial Results Read more about Amgen Announces Webcast of Third Quarter Financial Results
Amgen Foundation Donates $500,000 to South Asia Earthquake Relief Efforts Read more about Amgen Foundation Donates $500,000 to South Asia Earthquake Relief Efforts
Amgen Announces $5 Billion Stock Repurchase Plan Read more about Amgen Announces $5 Billion Stock Repurchase Plan
Treatment Has Demonstrated Improvement in Physical Function and Kept Joint Damage from Progressing at Three Years Read more about Treatment Has Demonstrated Improvement in Physical Function and Kept Joint Damage from Progressing at Three Years
Two-Year Trial Results of Amgen Investigational Therapy for Bone Loss, Denosumab, Show Increased Bone Mineral Density with Twice-Yearly Dosing Read more about Two-Year Trial Results of Amgen Investigational Therapy for Bone Loss, Denosumab, Show Increased Bone Mineral Density with Twice-Yearly Dosing
Data Show Aranesp(R) (Darbepoetin Alfa) Administered Once Monthly Maintains Hemoglobin Levels in Chronic Kidney Disease Patients with Anemia Read more about Data Show Aranesp(R) (Darbepoetin Alfa) Administered Once Monthly Maintains Hemoglobin Levels in Chronic Kidney Disease Patients with Anemia
Nominations Open for the Amgen Award for Science Teaching Excellence; 19 Outstanding Teachers Will Be Recognized in Communities Where Amgen Operates Read more about Nominations Open for the Amgen Award for Science Teaching Excellence; 19 Outstanding Teachers Will Be Recognized in Communities Where Amgen Operates
Amgen Files Lawsuit Against Roche for Patent Infringement Read more about Amgen Files Lawsuit Against Roche for Patent Infringement
Amgen Announces Sponsorship of World-Class Cycling Event; Company to Join with the Wellness Community to Raise Awareness and Funds to Help People Fight Cancer Read more about Amgen Announces Sponsorship of World-Class Cycling Event; Company to Join with the Wellness Community to Raise Awareness and Funds to Help People Fight Cancer
Panitumumab Significantly Improves Progression-Free Survival in Phase 3 Randomized Metastatic Colorectal Cancer Study Read more about Panitumumab Significantly Improves Progression-Free Survival in Phase 3 Randomized Metastatic Colorectal Cancer Study
